PROGRAM
Wednesday April 2, 9.00-12.00 - Teaching course
Johan Zelano and Francesco Brigo
Conference room: Europa, Wallenberg Center
09.00-09.15 Welcome
Francesco Brigo, Johan Zelano
09.15-10.00 Diagnosing epilepsy in other brain diseases
Johan Zelano
10.00-10.30 Coffee break
10.30-11.15 Epilepsy in patients with dementia
Francesco Brigo
11.15-12.00 Management of seizures at and after stroke
Francesco Brigo and Johan Zelano
12.00 Lunch
for delegates at the Teaching course
Wednesday April 2, 13.00-19.30 - STESS conference
Conference room: Wallenbergsalen
Session 1: Preclinical / epileptogenesis / disease modification
13.00-13.10 Opening remarks
Francesco Brigo and Johan Zelano
13.10-13.50 Preclinical multicenter-study of TBI in rodents: results and lessons learned from the EpiBioS4Rx
Asla Pitkanen, Finland
13.50-14.30 Interleukin-1 antagonism: an antiepileptogenic treatment?
Ronny Wickström, Sweden
14.30-15.00 Coffee break
15.00-15.40 Epilepsy in brain tumors: commonalities in tumorigenesis and epileptogenesis
Eleonora Aronica, the Netherlands
15.40-16.20 Antiepileptogenesis in first seizure-patients: too late or just right?
Tony Marson, UK
16.20-17.05 Platform session
3 x 15 min presentations
Novel serum biomarkers for the prediction of epilepsy after aneurysmal subarachnoid hemorrhage – An exploratory analysis
Daniel Campos
Early S100B Measures After Traumatic Brain Injury Provide a Biomarker for Epilepsy
Kacper Lolk
Post-traumatic epilepsy: Biomarkers, clinical and socioeconomic characteristics in a civilian population
Markus Karlander
17:15 The Importance of Diagnosing Lennox-Gastaut Syndrome (LGS): Why It Matters
Professor Ronny Wickström (Sweden), Professor Adam Strzelczyk (Germany) and Professor Jukka Peltola (Finland)
Welcome reception
You are invited to join the STESS 2025 Welcome Reception taking place in continuation of the symposium.
Sponsored by Jazz Pharmaceuticals
Thursday April 3 - STESS Conference
Session 2: Biomarkers
08.20-09.00 Acute symptomatic seizures and their relation to poststroke epilepsy
Marian Galovic, Switzerland
09.00-09.40 Immune responses after seizures
Christine Ekdal, Sweden
09.40-10.20 The role of EEG in acute and structural epilepsies
Sandor Benickzy, Denmark
10.20-10.50 Coffee break
10.50-11.30 Blood biomarkers in status epilepticus
Stefano Meletti, Italy
11.30-12.00 Blood biomarkers in chronic epilepsy
Johan Zelano, Sweden
12.00-12.25 Lunch
12.25-13.25 Rare epilepsy: Transition of care from pediatric to adult in Dravet and Lennox-Gastaut Syndromes
Prof Alexandre Datta, MD
Prof Bernhard Steinhoff, MD, PhD
Lunch symposium sponsored by UCB
Session 3: Diagnosis, treatment and prognosis
13.25-14.05 Epilepsy in Alzheimer’s disease
Francesco Brigo, Italy
14.05-14.45 Status epilepticus of acute and remote symptomatic etiology
Eugen Trinka, Austria
14.45-15.15 Coffee break
15.15-15.55 Autoimmune seizures
Stephan Ruegg, Switzerland
15.55-16.35 Antiepileptic drug treatment in patients with brain tumors
Simona Lattanzi, Italy
16.35-17.25 Platform session
3 x 15 min presentations
Sustained myoclonus in patients with refractory cardiac arrest supported by extracorporeal cardiopulmonary resuscitation (ECPR) and associated factors
Laura Abraira
Working years lost in people with epilepsy according to underlying aetiology: a population-based cohort study of 5,4 million people of working age
Julie Drier
Revisiting Acute Symptomatic Seizures: Timing as a Key Predictor of Seizure Recurrence After Stroke
Michael Schubert
Friday April 4 - STESS Conference
Session 4: Prognosis continued, Hot topics
08.20-09.00 SUDEP in structural epilepsies
Alberto Vogrig, Italy
09.00-09.40 Adverse cardiovascular events and ASM treatment
Josephine Mayer, UK
09.40-10.20 Polygenic risk of poststroke epilepsy
Nishant Mishra, US
10.20-10.50 Coffee break
10.50-11.30 Long-term prognosis of structural epilepsy from an epidemiological perspective
Jakob Christenssen
11.30-12.10 Eclampsia; acute and longterm effects on the maternal brain
Lina Bergman, Sweden
12.10 Lunch
Last update: March 25, 2025